Русский

Pharmaceutical Industry Information Portal

HomeTagsCoviVac

All posts by tag

CoviVac

All pharmaceutical industy news tagged with ‘CoviVac’.
CoviVac is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Center which is an institute of the Russian Academy of Sciences. It was approved for use in Russia in February 2021, being the third COVID-19 vaccine to get approval in Russia. It has not yet gone through a phase III clinical trial as of early March 2021.

Manufacturers News

NANOLEK began industrial production of the CoviVac vaccine

Techno -
NANOLEK announced the launch of industrial production of CoviVac. Investments in this project amounted to 40 million rubles, the company said. The manufacturer plans...
Manufacturers News

Chumakov Center plans to double CoviVac production in October, says director general

Techno -
The Chumakov Center plans to double the production of the CoviVac whole-virion vaccine against the coronavirus to 2.5 mln doses per month in October...
Manufacturers News

Russian Chumakov Center discusses CoviVac vaccine’s approval in Asia and US

Techno -
"We have just launched the third phase of clinical trials, therefore, it is too early to talk about the drug’s registration abroad," the Russian expert said.
Regulatory News

Antitrust watchdog sets maximum selling price for 50 doses of CoviVac vaccine at $297

Techno -
FAS has agreed on the maximum selling price for a new package of the CoviVac vaccine. The new form of vaccine release contains 50 doses.
Pharma marketing analytics

All the four national vaccines are produced rhythmically in line with the plans

Techno -
Russia has put into circulation about 32 million sets of coronavirus vaccines since the beginning of the year, and new sites are joining in...
Manufacturers News

Ministry of Health of the Russian Federation issues permit for post-registration trials of CoviVac

Techno -
The Russian Health Ministry has issued a permit to conduct the post-registration clinical trials of the CoviVac shot against the coronavirus infection with the...
12Page 1 of 2
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories